V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10005757 | 10003615 | 0 | 59.65 | Adjuvant (A) | 2014-04-12 | 2014-04-16 | Trastuzumab Subcutaneous | null | N | 10259113 | TRASTUZUMAB |
| 10005758 | 10003615 | 1.65 | 81.6 | Curative (C) | 2017-11-30 | 2017-12-06 | Capecitabine + Oxaliplatin 21day | 02 | N | 10259113 | CAPECITABINE + OXALIPLATIN |
| 10005759 | 10003617 | 1.63 | 70 | Curative (C) | 2018-09-14 | 2018-09-20 | CHOP R - 21 days | null | null | 10261071 | CHOP R |
| 10005760 | 10003618 | null | 94 | Palliative (P) | null | 2018-11-24 | Rituximab (Maintenance) | N | N | 10261233 | RITUXIMAB |
| 10005761 | 10003619 | 1.71 | 75.6 | Palliative (P) | 2017-03-25 | 2017-03-31 | PACLITAXEL | N | N | 10261233 | PACLITAXEL |
| 10005762 | 10003620 | 1.71 | 91.6 | Neo-adjuvant (N) | 2018-06-05 | 2018-06-06 | Trastuzumab Subcutaneous | N | N | 10262332 | TRASTUZUMAB |
| 10005763 | 10003621 | 1.71 | 75.6 | Disease modification (D) | 2017-05-17 | 2017-12-28 | Rituximab (SUBCUTANEOUS Maintenance) | N | N | 10262589 | RITUXIMAB |
| 10005764 | 10003621 | 1.78 | 87 | Palliative (P) | 2017-07-15 | 2017-11-26 | DOCETAXEL + Prednisolone | N | N | 10262589 | DOCETAXEL |
| 10005765 | 10003623 | 1.7 | 42.3 | Curative (C) | 2015-04-24 | 2015-04-30 | TRASTUZUMAB | N | N | 10265007 | TRASTUZUMAB |
| 10005766 | 10003624 | 1.63 | null | null | 2017-01-15 | 2017-02-26 | Oxaliplatin + Modified de Gramont | 2 | N | 10265848 | OXALIPLATIN + MDG |
| 10005767 | 10006959 | 1.7 | 71.2 | Curative (C) | 2016-09-24 | 2016-10-16 | Trastuzumab Subcutaneous | N | N | 10266032 | TRASTUZUMAB |
| 10005768 | 10006960 | 1.67 | 78.3 | Not known (9) | 2014-06-23 | 2014-06-25 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | 10266268 | PACLITAXEL |
| 10005769 | 10006960 | 1.56 | 77.1 | Palliative (P) | 2017-10-22 | 2017-10-23 | Capecitabine + Oxaliplatin 21day | N | N | 10266268 | CAPECITABINE + OXALIPLATIN |
| 10005770 | 10003626 | 1.85 | 74.9 | Curative (C) | 2018-01-03 | 2018-02-02 | CHOP R - 21 days | 02 | N | 10267419 | CHOP R |
| 10005771 | 10003628 | 1.71 | 66.3 | Curative (C) | 2016-07-03 | 2016-08-01 | PEMBROLIZUMAB | N | N | 10267492 | PEMBROLIZUMAB |
| 10005772 | 10003628 | 1.8 | 63.6 | Curative (C) | 2017-06-15 | 2017-07-06 | TRASTUZUMAB | N | N | 10267492 | TRASTUZUMAB |
| 10005773 | 10003630 | 1.65 | 55.5 | Not known (9) | 2015-10-11 | 2015-10-12 | Trastuzumab Subcutaneous | 2 | N | 10271784 | TRASTUZUMAB |
| 10005774 | 10003631 | 0 | 92.1 | Curative (C) | 2015-10-22 | 2015-11-06 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | 10273322 | PACLITAXEL |
| 10005775 | 10003631 | 1.68 | 61.6 | Palliative (P) | 2017-05-19 | 2017-09-01 | Paclitaxel 7 day | 02 | N | 10273322 | PACLITAXEL |
| 10005776 | 10003632 | 1.64 | 55 | Curative (C) | 2018-11-27 | 2018-12-01 | Oxaliplatin + Modified de Gramont | N | N | 10274979 | OXALIPLATIN + MDG |
| 10005777 | 10003633 | 1.8 | 89.2 | Curative (C) | 2018-07-02 | 2018-07-02 | PEMBROLIZUMAB | 02 | N | 10275064 | PEMBROLIZUMAB |
| 10005778 | 10003634 | 1.59 | 0 | Curative (C) | 2017-01-30 | 2017-02-06 | Oxaliplatin + Modified de Gramont | 02 | N | 10275183 | OXALIPLATIN + MDG |
| 10005779 | 10008330 | 1.61 | 58.2 | Disease modification (D) | 2016-10-23 | 2016-10-30 | Oxaliplatin + Modified de Gramont | 02 | N | 10275539 | OXALIPLATIN + MDG |
| 10005780 | 10003635 | 1.75 | null | Palliative (P) | 2018-10-30 | 2018-11-04 | FLUOROURACIL + FOLINIC ACID + OXALIPLATIN | N | N | 10275952 | OXALIPLATIN + MDG |
| 10005781 | 10006966 | null | 81.2 | Palliative (P) | 2018-05-06 | 2018-05-17 | Rituximab | N | N | 10275965 | RITUXIMAB |
| 10005782 | 10006966 | 1.73 | null | Adjuvant (A) | 2018-09-18 | 2018-10-10 | CHOP R - 21 days | N | N | 10275965 | CHOP R |
| 10005783 | 10003636 | null | 63 | Disease modification (D) | 2017-09-05 | 2017-09-14 | Irinotecan + De Gramont | N | N | 10276088 | IRINOTECAN + MDG |
| 10005784 | 10003637 | 0 | null | Palliative (P) | 2015-05-08 | 2015-05-17 | Docetaxel 75mg/m2 (21 day) | N | N | 10276298 | DOCETAXEL |
| 10005785 | 10003638 | 1.76 | 64.7 | null | 2018-10-20 | 2019-05-10 | Rituximab | N | N | 10276501 | RITUXIMAB |
| 10005786 | 10003639 | 1.74 | 80 | Curative (C) | 2015-05-23 | 2015-05-31 | Docetaxel 100mg/m2 (21 day) | 2 | N | 10276501 | DOCETAXEL |
| 10005787 | 10003640 | 1.74 | 73.4 | Curative (C) | 2015-04-23 | 2015-04-26 | Oxaliplatin + Modified de Gramont | 02 | N | 10276519 | OXALIPLATIN + MDG |
| 10005788 | 10003640 | 1.8 | 94.6 | Adjuvant (A) | 2018-01-16 | 2018-01-19 | Docetaxel 75mg/m2 (21 day) | 2 | N | 10276519 | DOCETAXEL |
| 10005789 | 10003641 | 1.8 | 74.2 | Palliative (P) | 2014-01-12 | 2014-03-27 | Docetaxel | N | N | 10276568 | DOCETAXEL |
| 10005790 | 10003642 | 1.79 | null | Palliative (P) | 2018-12-28 | 2018-12-29 | FLUOROURACIL + IRINOTECAN | N | N | 10276720 | IRINOTECAN + MDG |
| 10005791 | 10003642 | 1.7 | 82.6 | Adjuvant (A) | 2016-01-28 | 2016-01-29 | Rituximab | 2 | null | 10276720 | RITUXIMAB |
| 10005792 | 10003643 | 1.83 | 61.6 | Palliative (P) | 2018-09-27 | 2018-10-17 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | 10276753 | PACLITAXEL |
| 10005793 | 10003643 | 1.75 | null | Neo-adjuvant (N) | null | 2017-07-21 | Paclitaxel 7 day | 02 | N | 10276753 | PACLITAXEL |
| 10005794 | 10003643 | 1.67 | 98 | Palliative (P) | 2015-09-10 | 2015-09-11 | PEMBROLIZUMAB | N | null | 10276753 | PEMBROLIZUMAB |
| 10005795 | 10003644 | 1.78 | null | Adjuvant (A) | 2018-03-16 | 2018-03-21 | PEMBROLIZUMAB | null | null | 10277029 | PEMBROLIZUMAB |
| 10005796 | 10003647 | 1.63 | 89.2 | Adjuvant (A) | 2017-05-14 | 2017-05-14 | Docetaxel 100mg/m2 (21 day) | N | N | 10277666 | DOCETAXEL |
| 10005797 | 10003648 | 1.88 | 73.7 | Curative (C) | 2018-12-09 | 2018-12-15 | Rituximab (SUBCUTANEOUS Maintenance) | N | N | 10277795 | RITUXIMAB |
| 10005798 | 10003649 | 1.7 | 72.7 | null | null | 2016-12-22 | Docetaxel | N | null | 10277795 | DOCETAXEL |
| 10005799 | 10003650 | 1.61 | 56.4 | Curative (C) | null | 2015-06-13 | Docetaxel 100mg/m2 (21 day) | N | N | 10278226 | DOCETAXEL |
| 10005800 | 10003651 | 1.8 | null | Palliative (P) | 2016-03-05 | 2016-03-06 | Rituximab | N | N | 10278630 | RITUXIMAB |
| 10005801 | 10003652 | 1.71 | 79.2 | Palliative (P) | 2017-12-14 | 2017-12-14 | Docetaxel 100mg/m2 (21 day) | N | N | 10278698 | DOCETAXEL |
| 10005802 | 10003653 | 1.81 | 89.9 | Palliative (P) | 2017-12-13 | 2018-01-31 | PACLITAXEL | N | N | 10278786 | PACLITAXEL |
| 10005803 | 10003654 | 1.76 | 100.6 | Curative (C) | 2017-09-03 | 2017-09-03 | Trastuzumab Subcutaneous | 02 | N | 10278853 | TRASTUZUMAB |
| 10005804 | 10003655 | null | 56 | Disease modification (D) | 2016-09-02 | 2016-09-09 | Rituximab | N | N | 10279100 | RITUXIMAB |
| 10005805 | 10003656 | 1.74 | 75.5 | Palliative (P) | null | 2018-10-06 | Rituximab (SUBCUTANEOUS Maintenance) | 2 | N | 10279100 | RITUXIMAB |
| 10005806 | 10003659 | 1.5 | 72 | Palliative (P) | 2018-06-22 | 2018-06-22 | TRASTUZUMAB | 02 | N | 10279278 | TRASTUZUMAB |